Back to Pt-141 research
pt-141 2026-04-03 PubMed

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


pt-141 bremelanotide hsdd sexual-health women's-health phase-3 long-term
Source: pubmed:31599847 · Ingested Apr 3, 2026